We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Valuing Amersham

9 October 2003 By Robert Cyran

The shares currently trade at breakup value, but no takeover premium has been added. Any acquirer is likely to split up the UK medical services company.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)